Novartis (NOVN SW) CFO says current guidance is the right one at this moment

Context

Novartis' CFO reaffirming the current guidance suggests confidence in their operational outlook, which may stabilize sentiment around the stock. This statement could indicate that recent market fluctuations or analyst concerns are being addressed, maintaining investor trust in Novartis' strategy and performance. Investors should consider how this aligns with broader sector trends and peer performance, as it may provide a clearer signal regarding the company's resilience in the current market environment.

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#SWITZERLAND#NOVARTIS AG#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#SWISS MARKET INDEX#NOVN#SMI
Published: Updated: